Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2008-11-13
2010-10-05
Saoud, Christine J (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C530S387900, C530S389700, C530S350000
Reexamination Certificate
active
07807385
ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: 6613515 (2003-09-01), Xu et al.
patent: 6617109 (2003-09-01), Xu et al.
patent: 6710170 (2004-03-01), Xu et al.
patent: 6720146 (2004-04-01), Stolk et al.
patent: 7144990 (2006-12-01), Goddard et al.
patent: 7157558 (2007-01-01), Goddard et al.
patent: 7208316 (2007-04-01), Goddard et al.
patent: 7598051 (2009-10-01), Fanger et al.
patent: 2003/0129192 (2003-07-01), Chenault et al.
patent: 2003/0148408 (2003-08-01), Frantz et al.
patent: 2003/0206918 (2003-11-01), Fanger et al.
patent: 2003/0232056 (2003-12-01), Fanger et al.
patent: 2004/0229277 (2004-11-01), Frantz et al.
patent: 2004/0242860 (2004-12-01), Frantz et al.
patent: 2006/0057141 (2006-03-01), Fanger et al.
patent: 1 067 182 (2001-01-01), None
patent: WO 00/61629 (2000-10-01), None
patent: 00/77026 (2000-12-01), None
patent: 01/18046 (2001-03-01), None
patent: 01/81634 (2001-11-01), None
patent: 01/92581 (2001-12-01), None
patent: WO 02/39885 (2002-05-01), None
patent: 2007/109567 (2007-09-01), None
Takaba et al. (2000). Carcinogenesis. 21(4):691-700.
U.S. Appl. No. 11/687,309, filed Mar. 16, 2007, Liang et al.
U.S. Appl. No. 12/012,201, filed Jan. 31, 2008, Goddard et al.
Ballow et al., “Immunopharmacology, Immunomodulation and Immunotherapy”Journal of the American Medical Assn. 278:2008-2017 (1997).
Bork, et al., “Go hunting in sequence databases but watch out for the traps”Trends in Genetics12(10):425-427 (Oct. 1996).
Bork, P., “Powers and Pitfalls in Sequence Analysis: The 70% Hurdle”Genome Research10(4):398-400 (Apr. 2000).
Brenner, S.E., “Errors in genome annotation”Trends in Genetics15(4):132-133 (Apr. 1999).
Buchsbaum et al., “Experimental radioimmunotherapy”Med. Phys. 20(2):551-567 (1993).
Chen et al., “Discordant Protein and mRNA Expression in Lung Adenocarcinomas”Molecular&Cellular Proteomics1:304-313 (2002).
Database Search, DNA sequence alignments, (BLASTN 2.2.6 Apr. 9, 2003 NCBI) pp. 1-118.
Database Search, protein sequence alignments, (BLASTP 2.2.6 Apr. 9, 2003 NCBI) pp. 1-18.
Dillman, R.O., “Monoclonal antibodies in the treatment of malignancy: basic concepts and recent developments”Cancer Invest19(8):833-841 (2001).
Doerks, et al., “Protein annotation: detective work for function prediction”Trends in Genetics14(6):248-250 (Jun. 1998).
EMBL Sequence DatabaseAccession No. AA613995(Oct. 13, 1997).
Ex parte Baker et al., USPTO Board of Patent Appeals and Interferences, Appeal No. 2007-2230 in U.S. Appl. No. 10/187,744, decided Sep. 17, 2007.
Explanation of blast hits—DNA sequence alignments: GenBank (Rel 153 Apr. 2006) pp. 119-166.
Explanation of blast hits—protein sequence alignments: Dayhoff Protein Database (Rel 48 Oct. 2005) pp. 19-53.
Haynes et al., “Proteome analysis: Biological assay or data archive?”Electrophoresis19:1862-1871 (1998).
Hegde et al., “A Concise Guide to cDNA Microarray Analysis”BioTechniques29(3):548-562 (Sep. 2000).
Hu et al., “Analysis of genomic and proteomic data using advanced literature mining”J. Proteome Res2:405-412 (2003).
Moore, G.P., “Genetically Engineered Antibodies”Clinical Chemistry35(9):1849-1853 (1989).
NCBI Database,Accession No. AB041649(Jun. 30, 2000).
NCBI Database, Accession No. AX136281 (May 30, 2001).
NCBI Database, Accession No. Q9JJ96 (Oct. 1, 2000).
Ngo et al., “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox”The Protein Folding Problem and Tertiary Structure Prediction, Merz & Le Grand, Boston:Birkhauser pp. 491-495 (1994).
Orntoft, Torben F., et al., “Genome-wide Study of Gene Copy Numbers, Transcripts, and Protein Levels in Pairs of Non-Invasive and Invasive Human Transitional Cell Carcinomas”Molecular&Cellular Proteomics1:37-45 (2002).
Osband et al., “Problems in the investigational study and clinical use of cancer immunotherapy”Immunology Today11(6):193-195 (1990).
Pennica D, et al., “WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-l-transformed cells and aberrantly expressed in human colon tumors”Proc. Natl. Acad. Sci. USA95(25):14717-14722 (Dec. 8, 1998).
Preliminary Amendment filed with Reissue Application No. 12/012,201 (for U.S. Patent No. 7,208,316 B2) (Filed Jan. 31, 2008).
Qi et al., “Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells”Proc. Natl. Acad. Sci USA100:3305-3310 (2003).
Reissue Application Declaration by the Assignee filed in Reissue Application 12/012,201 (for U.S. Patent No. 7,208,316 B2) (Filed Jan. 31, 2008).
Saito-Hisaminato et al., “Genome-wide profiling of gene expression in 29 normal human tissues with a cDNA microarray”DNA Res9:35-45 (2002).
Schlom, J., “Monoclonal Antibodies: They're More and Less Than You Think”Molecular Foundations of Oncology, Broder, S. ed., Baltimore, MD:Williams & Wilkins, Chapter 6, pp. 95-134 (1991).
Seaver, “Monoclonal Antibodies in Industry: More Difficult Than Originally Thought”Genetic Engineering Newspp. 10 and 21 (Aug. 1994).
Sen et al., “Aneuploidy and cancer”Curr. Opin. Oncol. 12:82-88 (2000).
Skolnick et al., “From Genes to protein structure and function: novel applications of computational approaches in the genomic era”TIBTECH18:34-39 (Jan. 2000).
Smith, et al., “The challenges of genome sequence annotation or “The devil is in the details””Nature Biotechnology15(12):1222-1223 (Nov. 1997).
Trail et al., “Monoclonal antibody drug conjugates in the treatment of cancer”Current Opinion in Immunology11:584-588 (1999).
Wawrzynczak et al., “Strategies in antibody therpay of cancer”Clin. exp. Immunol. 82:189-193 (1990).
Wells, “Additivity of Mutational Effects in Proteins”Biochemistry29:8509-8517 (1990).
Goddard Audrey
Godowski Paul J.
Gurney Austin L.
Smith Victoria
Wood William I.
Genentech Inc.
Lockard Jon M
Pasqualone Danielle M.
Saoud Christine J
LandOfFree
Method of detecting PRO9917 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of detecting PRO9917, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of detecting PRO9917 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4225944